ATE299936T1 - Fas antigen-derivate - Google Patents
Fas antigen-derivateInfo
- Publication number
- ATE299936T1 ATE299936T1 AT97918354T AT97918354T ATE299936T1 AT E299936 T1 ATE299936 T1 AT E299936T1 AT 97918354 T AT97918354 T AT 97918354T AT 97918354 T AT97918354 T AT 97918354T AT E299936 T1 ATE299936 T1 AT E299936T1
- Authority
- AT
- Austria
- Prior art keywords
- fas antigen
- amino acid
- derivative
- antigen derivative
- fas
- Prior art date
Links
- 108010052621 fas Receptor Proteins 0.000 title abstract 8
- 102000018823 fas Receptor Human genes 0.000 title abstract 8
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13576096 | 1996-05-02 | ||
| PCT/JP1997/001502 WO1997042319A1 (fr) | 1996-05-02 | 1997-05-01 | NOUVEAUX DERIVES DE L'ANTIGENE Fas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE299936T1 true ATE299936T1 (de) | 2005-08-15 |
Family
ID=15159230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97918354T ATE299936T1 (de) | 1996-05-02 | 1997-05-01 | Fas antigen-derivate |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6306395B1 (de) |
| EP (1) | EP0965637B1 (de) |
| AT (1) | ATE299936T1 (de) |
| AU (1) | AU2650597A (de) |
| CA (1) | CA2253494A1 (de) |
| DE (1) | DE69733773T2 (de) |
| WO (1) | WO1997042319A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6905684B1 (en) | 1997-11-10 | 2005-06-14 | Mochida Pharmaceutical Co., Ltd. | Preventives and remedies for diffuse lung diseases |
| ATE361119T1 (de) * | 1998-05-14 | 2007-05-15 | Mochida Pharm Co Ltd | Prävention und therapie von leberzirrhosen |
| EP1082967B1 (de) | 1998-05-29 | 2006-07-19 | Mochida Pharmaceutical Co., Ltd. | Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten |
| US6942981B1 (en) * | 1999-05-14 | 2005-09-13 | Arbor Vita Corporation | Method of determining interactions with PDZ-domain polypeptides |
| US20050037969A1 (en) * | 1999-05-14 | 2005-02-17 | Arbor Vita Corporation | Molecular interactions in hematopoietic cells |
| ATE324444T1 (de) * | 1999-06-07 | 2006-05-15 | Immunex Corp | Tek-antagonisten |
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| EP1418935A1 (de) * | 2001-08-01 | 2004-05-19 | Genset S.A. | Genobix agonisten und antagonisten zur verwendung bei der behandlung von stoffwechselkrankheiten |
| GB2381122B (en) * | 2001-10-16 | 2006-04-05 | Zetex Plc | Termination structure for a semiconductor device |
| US7910694B2 (en) * | 2002-09-19 | 2011-03-22 | Cornell Research Foundation, Inc. | Homing peptides to receptors of heart vasculature |
| EP1606319A2 (de) | 2003-03-26 | 2005-12-21 | Apogenix GmbH | Behandlung viraler infektionen |
| ES2420582T3 (es) | 2006-12-28 | 2013-08-26 | Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts | La neutralización de la actividad de CD95 bloquea la invasión de células de glioblastoma in vivo |
| US20090196868A1 (en) * | 2007-09-06 | 2009-08-06 | Apogenix Gmbh | Methods and compositions for preventing radiation-induced pneumonitis |
| EP3144320B9 (de) * | 2011-04-13 | 2018-08-22 | Bristol-Myers Squibb Company | Fc-fusionsproteine mit neuartigen linkern oder anordnungen |
| JP6231562B2 (ja) * | 2012-07-18 | 2017-11-15 | アポジェニックス アーゲー | ＣＤ９５−Ｆｃアイソフォームの混合物を含む組成物 |
| RU2652348C2 (ru) | 2012-07-18 | 2018-04-25 | Аподжиникс Аг | Ингибиторы сигнального пути cd95 для лечения мдс |
| EP3076179A1 (de) | 2015-03-30 | 2016-10-05 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Diagnose und behandlung von minderwertigen glioma |
| CN114269370A (zh) | 2019-03-29 | 2022-04-01 | 迈斯特治疗公司 | 离体产生t细胞治疗剂的方法以及相关的组合物和方法 |
| JP2023504042A (ja) | 2019-11-27 | 2023-02-01 | ミスト セラピューティクス リミテッド ライアビリティ カンパニー | 調節物質を使用した腫瘍反応性ｔ細胞組成物の生成方法 |
| MX2022010517A (es) | 2020-02-27 | 2022-11-14 | Myst Therapeutics Llc | Metodos para la expansion y enriquecimiento ex vivo de celulas t reactivas a tumor y composiciones relacionadas de las mismas. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| CA2067031C (en) * | 1991-04-26 | 2003-02-18 | Shigekazu Nagata | Dna coding for human cell surface antigen |
| US5770197A (en) | 1991-06-27 | 1998-06-23 | Bristol-Myers Squibb Company | Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| JPH08127594A (ja) | 1993-11-10 | 1996-05-21 | Mochida Pharmaceut Co Ltd | Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ |
| JPH07289266A (ja) | 1994-04-21 | 1995-11-07 | Mochida Pharmaceut Co Ltd | ヒトＦａｓ抗原バリアント及びそれをコードする新規ＤＮＡ |
-
1997
- 1997-05-01 CA CA002253494A patent/CA2253494A1/en not_active Abandoned
- 1997-05-01 AT AT97918354T patent/ATE299936T1/de not_active IP Right Cessation
- 1997-05-01 DE DE69733773T patent/DE69733773T2/de not_active Expired - Lifetime
- 1997-05-01 US US09/180,100 patent/US6306395B1/en not_active Expired - Fee Related
- 1997-05-01 WO PCT/JP1997/001502 patent/WO1997042319A1/ja active IP Right Grant
- 1997-05-01 AU AU26505/97A patent/AU2650597A/en not_active Abandoned
- 1997-05-01 EP EP97918354A patent/EP0965637B1/de not_active Expired - Lifetime
-
2001
- 2001-09-12 US US09/949,713 patent/US6953847B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997042319A1 (fr) | 1997-11-13 |
| CA2253494A1 (en) | 1997-11-13 |
| EP0965637A4 (de) | 2002-09-25 |
| DE69733773T2 (de) | 2006-04-20 |
| EP0965637B1 (de) | 2005-07-20 |
| US6306395B1 (en) | 2001-10-23 |
| EP0965637A1 (de) | 1999-12-22 |
| DE69733773D1 (de) | 2005-08-25 |
| US6953847B2 (en) | 2005-10-11 |
| US20020044944A1 (en) | 2002-04-18 |
| AU2650597A (en) | 1997-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69733773D1 (de) | Fas ANTIGEN-DERIVATE | |
| DK0670898T3 (da) | Interleukin-3 (IL-3)-mutantpolypeptider | |
| PT662827E (pt) | Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos | |
| ATE251642T1 (de) | Biologisch aktive fragmente des glucagon ähnlichen, insulinotropen peptides | |
| NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
| EP0333356A3 (de) | Hirudin-Peptide | |
| NO964650D0 (no) | LAG-3 protein-opplöselige polypeptidfraksjoner, fremgangsmåte for fremstilling, teraupeutisk preparat og anti-idiotype antistoff | |
| KR960704934A (ko) | 항혈전활성을 갖는 펩티드 및 이의 제조방법(Peptide having antithrombotic activity and process for producing the same) | |
| MY127575A (en) | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | |
| ATE189684T1 (de) | Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose | |
| ATE488249T1 (de) | Immunologisch bedeutende herpes-simplex-virus- antigene und verfahren für ihre verwendung | |
| HUT69169A (en) | T-cell-suppressive peptide fragments of human myelin basic protein (hmbp) and pharmaceutical compositions containing them | |
| ATE154638T1 (de) | Mutanten von interleukin-3 | |
| NZ508816A (en) | Bactericidal/permeability-increasing protein (BPI) deletion analogs | |
| DE60313982D1 (de) | Dimere von thrombinpeptidderivaten | |
| ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
| AU6961601A (en) | Transport peptides among which c-terminal E<sup>rns</sup> peptide and analogues thereof | |
| MX9203175A (es) | Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion. | |
| WO2000058465A3 (en) | Flint polypeptide analogs | |
| PE20010316A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS | |
| NO20011263D0 (no) | Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav | |
| WO2003022867A3 (en) | Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag | |
| PT1062348E (pt) | Onconase recombinante e proteinas de fusao de onconase recombinante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |